SMS Lifesciences India Ltd. engages in manufacturing and selling of active pharmaceutical products. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2017-08-17. The firm's products include Ranitidine HCL (Form-2) USP / Ph.Eur, Famotidine USP / Ph. Eur / JP, Itraconazole USP / Ph.Eur / JP, Lanoconazole USP / JP and Sildenafil Citrate USP / Ph.Eur. The firm's manufacturing facilities are located at Kazipally and Jeedimetla, Hyderabad. The firm's wholly owned subsidiary is Mahi Drugs Private limited.
Loading chart…
This company hasn't held an earnings call in the last six months, so there's no recent commentary from management. Our deep dives are built on what management actually said, so we haven't prepared one.